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Abstract 
What determines the degree of cell-resistance or sensitivity to ionizing radiation is not yet known. As a corollary to the 
ability of ceramide to induce apoptosis, some questions arise as to whether malignant cells escape apoptosis because of their 
inability to mount a ceramide response to inducers of apoptosis. To shed more light on the molecular mechanisms of tumor 
cell response to radiation, we tested whether exposure to ionizing radiation (of 200-1000 cGy) is associated with changes in 
ceramide levels in A431 tumor epithelial cells and whether the ability of ceramide to induce apoptosis is inhibited by 
protein kinase C (PKC) actiivation. Our studies demonstrate animmediate decrease in cellular levels of ceramide in response 
to radiation, while sphingosine levels increase. Under the same conditions the cellular 1,2-diacylglycerol (DAG) levels 
decrease as well, being accompanied by the translocation of PKC a from the membrane to the cytoplasm. Elevation of 
membrane PKC levels by 12-O-tetradecanoylphorbol 13-acetate (TPA) treatment had no effect on cell survival after 
irradiation, while treatment with EGF during and after irradiation augmented cell survival. Moreover, monoclonal ntibodies 
to the EGF receptor (EGFR) sensitize cells to radiation by facilitating radiation-induced apoptosis. It is thus plausible that in 
human Squamous carcinoma cells, radiation activates predominantly the EGFR to induce resistance, while both sphingo- 
myelin and PKC signal transduction pathways are deactivated and demonstrate no significant role in the modulation of the 
sensitivity or the resistance of A431 cells to ionizing radiation. 
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1. Introduction 
Current radiotherapy has minimal impact on the 
survival of cancer patients with malignancies resis- 
tant to treatment. The molecular basis of radiation 
* Corresponding author. Fax: + 1 (916) 7522949. 
sensitivity and resistance in mammalian cells is un- 
known and there is little information on their control 
mechanisms. Understanding the molecular pathways 
of these clinical treatments would enhance the 
prospects for therapeutic benefits. 
Ionizing radiation has been shown to induce apop- 
tosis in bovine aortic endothelial cells (BAEC) by 
activating sphingomyelin hydrolysis to ceramide [1]. 
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This pathway mediates the signaling of several cy- 
tokines, such as TNFa [2] and ILl[3 [3] and has been 
shown to constitute the early events in the induction 
of apoptotic DNA degradation and cell death [4,5]. In 
these systems, stimulation of cell surface receptors 
activates a plasma membrane neutral sphingomyeli- 
nase that hydrolyzes phingomyelin to generate ce- 
ramide and phosphocholine. We have shown [6] that 
ceramide then serves as a second messenger, phos- 
phorylating EGFR and thereby transmodulating its 
auto-phosphorylating activity. The signaling events 
further downstream are only partially known, but 
phosphorylation of the p42 isoform of MAP kinase 
[7] and nuclear translocation of NFkB [8] have been 
reported. In fact, activation of PKC by phorbol esters 
or 1,2-diacylglycerol (DAG) antagonized apoptosis 
through the sphingomyelin pathway [4], but the de- 
tailed molecular events in ceramide-induced apopto- 
sis are still unknown. 
We hypothesize that there are at least three cell 
membrane checkpoints that are modulated by radia- 
tion and that may determine whether the cell will 
enter apoptosis and die, or survive and grow: Activa- 
tion of the sphingomyelin pathway to generate ce- 
ramide turns on the signal for apoptosis, while activa- 
tion of the EGFR and/or PKC may counter this 
effect and enhance cell survival. The net response of 
a cell to radiation may thus depend on the balance 
between the lipid messengers ceramide and DAG, 
while EGFR acting as a molecular switch between 
mitogenic and growth inhibitory signals. 
Cancer cells bypass the requirement for growth 
factors by autocrine secretion of these factors, in- 
creased expression of growth-factor receptors, and by 
autonomous activation of biochemical pathways regu- 
lated by the growth factors [9-11]. Overexpression f 
EGFR has been shown to be correlated with malig- 
nancy and may have an important role in the devel- 
opment of cancer and cell resistance to radiation. 
Hallahan et al. [12] and Witte et al. [13] were the 
first to report the release of growth factors and 
cytokines by irradiated normal and tumor cells, and 
showed that stimulation by these peptides either in- 
duced repair of radiation lesions [13] or enhanced 
X-ray cell killing [12]. For example, X-ray induction 
of PDGF and FGF stimulates proliferation of vascu- 
lar endothelial cells [13], whereas induction of TNFa 
was postulated to produce autocrine and paracrine 
tumor cell killing [12]. Haimovitz-Friedman et al. 
[14] showed that radiation induced synthesis of bFGF 
in BAEC cells and reported that bFGF served as a 
specific inducer to repair radiation-damage in these 
cells [15]. Decreased radiosensitivity was also ob- 
served in the breast cancer cell line MCF-7, where 
incubation of cells with EGF resulted in growth 
stimulation and radioresistance [16]. Kwok and 
Sutherland [17] correlated the number of high affinity 
EGFR with the degree of sensitivity of cells to 
radiation and concluded that radiosensitivity is 
EGFR-density dependent. We have recently shown 
that EGFR tyrosine phosphorylation is increased in 
response to radiation or EGF treatment of A431 cells, 
and that the EGF treatment protects these cells against 
radiation damage [18]. Radiation may therefore mimic 
the action of a natural ligand on its receptor and 
trigger esistance or sensitivity to radiation by recep- 
tor activation. 
The present studies in A431 cells demonstrate hat 
radiation activates predominantly the EGFR to induce 
resistance, while both sphingomyelin and PKC path- 
ways are deactivated and may play only a secondary 
role in radiation-induced sensitization or resistance of 
human Squamous carcinoma A431 cells. 
2. Materials and methods 
2.1. Materials 
Anti-PKC antibodies and PKC-detection kit: 
Amersham, Arlington Heights, IL. EGF and 1,2-di- 
acylglycerol (DAG) kinase: Calbiochem, San Diego, 
CA. DAG: Serdary Research Labs., Englewood Cliffs, 
NJ. LA22 (Anti-Human EGF Receptor): Upstate 
Biotechnology Inc. Lake Placid, NY. All other chem- 
icals were obtained from Sigma, St. Louis, MO. 
2.2. Cell cultures and irradiation conditions 
A431 cells were grown in monolayers in growth 
med ium (Du lbecco 's  mod i f ied  Eag le ' s  
medium/Ham' s F- 12 ( 1:1) containing 5% NC S). The 
cells were seeded at 105 cells/35 mm culture dishes 
in growth medium. The cells were grown to 50% 
confluence and then treated with either 20 nM EGF 
or with different doses of radiation. Radiation was 
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delivered to cells kept on ice, in a Gamma-cell 40 
chamber containing two sources of 137 Cs (Atomic 
Energy of Canada) at a dose rate of 100 cGy/min. 
Cells were exposed to single doses ranging from 200 
cGy to 1000 cGy. 
2.3. PKC activity 
A431 cells were harvested by scraping with a 
rubber policeman in coM buffer A (20 mM Tris-HC1, 
pH 7.5, 250 mM sucrose, 6 mM EDTA, 0.5 mM 
dithiothreitol (DT-F), supplemented with protease in- 
hibitors 0.5 mM PMSF, 50 /zg/ml leupeptine, and 
20 /~g/ml aprotinin). The cells were sonicated for 1 
min in a bath sonicator and centrifuged at 500 X g 
for 5 min at 4°C to remove nuclei and whole cells. 
The cytosolic fraction was separated from the mem- 
branes by centrifugation at 100000 × g for 1 h. 
Membrane-bound PKC was solubilized by resuspend- 
ing the pellet in buffer A containing 0.5% Triton 
X-100 for 20 min on ice, and centrifuged for 30 min 
at 100000 X g to remove non-soluble material. Both 
the cytoplasmic and the solubilized membrane frac- 
tion were applied to a 0.2 ml anion exchange chro- 
matography DEAE-cellulose (DE-52) column, 
washed with buffer B (20 mM Tris, pH 7.5, 2 mM 
EDTA and 5 mM EGTA). Bound PKC was eluted 
batchwise with 500 ml buffer C (buffer B containing 
0.15 M NaC1). PKC activity was detected using the 
PKC enzyme assay kit (Amersham), according to the 
manufacturer's in tructions. 
2.4. Immunoblotting of PKC: Western blotting 
Protein fractions containing PKC which were 
eluted from the DE-52 columns (see above) were 
separated on SDS 10% PAGE, western blotted onto a 
nitrocellulose membrane, and membranes blocked in 
3% BSA in PBS. PKC was detected by incubating 
the membrane in specific antibodies directed against 
the various PKC isozymes (1:1000 in PBS). Bound 
antibodies were detected using protein A conjugated 
horse radish peroxidase. Blots were scanned with an 
LKB Ultrascan XL densitometer to quantify PKC 
immunoreactivity. 
2.5. Extraction and analysis of DAG and ceramide 
Ceramide and DAG were determined by the dia- 
cylglycerol kinase assay, according to Preiss et al. 
[19]. Briefly, cells were washed with cold PBS, 
scraped, centrifuged, and lipids extracted from cell 
pellet with 1 ml chloroform/methanol/HC1 
(100:100:1, v/v) and 0.3 ml of a buffered saline 
solution (135 mM NaC1, 4.5 mM KC1, 1.5 mM 
CaC12, 0.5 mM MgCI2, 5.6 mM glucose, 10 mM 
Hepes, pH 7.2, and 10 mM EDTA). The organic 
phase containing ceramide and DAG were evapo- 
rated. DAG kinase assay was carried out as de- 
scribed. Briefly, the evaporated lipid fractions were 
resuspended in 20 /~1 of an octyl-/3-D- 
glucoside/cardiolipin solution (7.5% octyl-/3-D-glu- 
coside, 5 mM cardiolipin in 1 mM DETAPAC) by 
sonication in a bath sonicator (50/60 Hz, Branson) 
for 15 s followed by incubation at room temperature 
for 15 min. The reaction buffer was prepared as a 
2 X solution, containing 100 mM imidazole HC1, pH 
6.6, 100 mM NaC1, 25 mM MgC1 z and 2 mM 
EGTA. To the solubilized lipid/octylglucoside solu- 
tion was added 50 ml of the 2 × reaction buffer, 2 
/zl 100 mM DTT, DAG kinase (0.022 U) and volume 
completed to 90 ml with water. The reaction was 
started by the addition of 1 /xl of 10 mCi/ml [3- 
32p]ATP and allowed to proceed for 30 min at 25°C. 
Reaction was stopped by the addition of 
chlorofor/methanol/HC1 (100:100:1, v/v), the chlo- 
roform phase collected, evaporated, resuspended in 
10 /zl chloroform/methanol (1:1, v/v) and spotted 
on a Silica Gel 60 thin layer chromatography. Plate 
was developed with chloroform/methanol/acetic 
acid (65:15:5, v/v), air dried and autoradiographed. 
The spots corresponding to DAG and ceramide were 
scanned in a densitometer and presented as density 
units. 
2.6. Extraction and analysis of sphingosine 
Sphingosine was extracted and quantified accord- 
ing to Merrill et al. [20]. Briefly, cells were washed 
in cold PBS, scraped, centrifuged, and pellet resus- 
pended in 0.5 ml chloroform/methanol (1:2, v/v), 
mixed thoroughly, and 0.5 ml chloroform and 0.5 ml 
water were added to separate the phases. The chloro- 
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form phase was collected, washed twice with water 
and evaporated. Evaporated lipids were resuspended 
in 0.5 ml of 0.1 M KOH in methanol/chloroform 
(2:1, v /v)  and incubated at 37°C for 1 h. 0.5 ml each 
of chloroform and water were added, chloroform 
phase collected and evaporated. The lipids were dis- 
solved in 50 ml methanol, mixed with 50 ml O- 
phthalaldehyde (OPA) reagent which was prepared 
fresh by mixing 99 ml 3% boric acid in water (pH 
10.5, which was adjusted with KOH) and 1 ml of 
ethanol containing 5 mg of OPA and 50 ml of 
2-mercaptoethanol. After 10 min incubation at room 
temperature, 400 ml methanol-5 mM potassium phos- 
phate (pH 7.0) (90:10, v /v)  was added. Aliquots 
were injected into a reverse phase C 18 HPLC column 
(Reinin column, LC-600 Shimadzu HPLC), in 
methanol-5 mM potassium phosphate (pH 7.0) (90:10, 
v/v),  at a flow rate of 2 ml/min. A fluorescence 
spectrophotometer (Hitachi) was used as a detector, 
with an excitation wavelength of 360 nm and an 
emission wavelength of 455 nm. To identify the peak 
containing sphingosine, a solution of 16.7 nM com- 
mercially available sphingosine was treated as above 
and run on the same column. 
2.7. Survival of A431 cells after irradiation 
Survival after irradiation was defined as the ability 
of the cells to maintain their clonogenic apacity [14]. 
After irradiation, cells were removed by treatment 
with 0.05% trypsin for 15 min at 37°C, washed in 
PBS, resuspended in growth medium (see above), 
and seeded for colony formation in 35 mm dishes at 
300-3000 cells/dish. After 7 days, the cultures were 
fixed in 3.7% formaldehyde and stained with 1% 
crystal violet in ethanol. Colonies consisting of 50 
cells or more were scored. The capacity to repair 
radiation lesions (Dq) was generated by a computer- 
assisted program [21] which calculates the best fit 
curves according to the single-hit multitarget model 
[22] by iterative weighted least square regression 
analysis of all data points, estimating the covariance 
of the survival curve parameters and the correspond- 
ing confidence limits. 
2.8. Apoptosis 
Apoptosis was analyzed using the ELISA Cell 
Death kit (Boehringer), which quantifies colorimetri- 
cally production of short DNA fragments. The assay 
was carried out according to the manufacturer's in- 
structions. 
3. Results 
3.1. Sphingomyelin pathway is downregulated in ir- 
radiated A431 cells 
To test whether radiation affects the sphingo- 
myelin signal transduction pathway, both ceramide 
and sphingosine l vels were measured. Ceramide lev- 
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Fig. 1. The effect of radiation on cellular levels of ceramide and 
sphingosine. A431 cells were exposed to increasing doses of 
radiation and allowed to recover for 30 s (A) or cells were 
exposed to 500 cGy and allowed to recover for 30 and 300 s (B), 
lipids extracted, and ceramide and sphingosine levels measured. 
For sphingosine determination, lipids were labeled with OPA, 
applied on a C18 reverse phase column, and the peak correspond- 
ing to sphingosine was measured. The highest amount of sphin- 
gosine detected in the specific experiment represents 100%. 
Ceramide levels were determined using the DAG kinase assay, 
where the amount of ceramide in untreated cells represent 100%. 
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els were tested by using the DAG kinase assay [19] 
and sphingosine was measured by reverse-phase col- 
umn chromatography [20]. Our  results show that 
ceramide levels decrease in irradiated cells (Fig. 1) 
while sphingosine levels increase. The decrease in 
ceramide levels was detected within seconds after 
radiation exposure, while the increase in sphingosine 
levels was more pronounced within minutes after 
radiation treatment. Ceramide levels were measured 
30 min and 1 h after radiation and remained 50% 
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Fig. 2. The effects of radiation dose of 500 cGy (A) and 20nM EGF (B) on PKC activity. A431 cells were irradiated or treated with EGF. 
At the indicated times, cells were collected, cytoplasmic and membranal PKC purified, and PKC activity measured. Activity of PKC in 
untreated cells is considered as 100%. Results are expressed as % of control. The effect of radiation dose of 500 cGy (C) and 20 nM EGF 
(D) on cytoplasmic PKC re. A431 cells were irradiated or treated with EGF. At the indicated times, cells were collected, cytoplasmic 
PKC purified, PKC activity tested, and purified PKC was applied to SDS 10% PAGE and western blotted. PKC a was detected using 
antibodies directed against PKC o~ and bound antibody was detected using peroxidase-conjugated Protein A. 1-5 corresponds to0, 15, 
30, 60 and 300 s, respectively. 
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plasm parallels the increase in PKC activity in the 
cytoplasm. 
DAG is the physiological activator of PKC [23], 
thus we determined the levels of DAG in irradiated 
or EGF-treated cells. DAG levels were measured by 
using the DAG kinase assay [19]. As shown in Fig. 3, 
radiation caused an immediate decrease in DAG con- 
tent. Both the drop in DAG levels and the downregu- 
lation of membranal PKC occur within seconds after 
exposure to radiation. Similar results were obtained 
when the cells were treated with 20 nM EGF (not 
shown). 
Fig. 3. The effect of radiation on cellular levels of DAG. (A) 
A431 cells were exposed to increasing doses of radiation, were 
allowed to recover for 30 s, lipids extracted, and DAG levels 
were determined using the DAG kinase assay. (B) Cells were 
exposed to 500 cGy, were allowed to recover for various lengths 
of time, and DAG levels determined, as in A. The level of DAG 
in untreated cells is considered as 100%. Results are expressed as 
% of control. 
lower than control levels ceramide (not shown). Of 
note is the fact that ceramide levels did not change in 
EGF-treated cells (not shown). 
3.2. DAG and PKC are down regulated in irradiated 
A431 cells 
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A431 cells were exposed to 500 cGy, allowed to 
recover for various lengths of time, and PKC activity 
was measured both in the membrane and in the 
cytosol. As shown in Fig. 2A, within 30 s after 
irradiation, PKC activity increased by 2-fold in the 
cytosol and decreased by 2-fold in the membrane. 
The same was observed when A431 cells were treated 
with 20 nM EGF (Fig. 2B). 
To test which PKC isozyme is associated with the 
translocation of PKC activity from the membrane to 
the cytoplasm, irradiated and EGF-treated cells were 
western blotted and probed with antibodies directed 
against he various PKC isozymes. Of all antibodies 
tested (PKC ol, /3, z and e), only anti-PKC oz bind- 
ing could be detected. As shown in Fig. 2C and Fig. 
2D, after irradiation of A431 cells with 500 cGy (Fig. 
2C) or treatment of cells with 20 nM EGF (Fig. 2D), 
the amount of PKC a increases in the cytosol. The 
kinetics by which PKC ce translocated to the cyto- 
o= .a= 
10-1 
10 -2 
l DRUG 
0 EGF 
T T A no~ Y ± 
. . . .  i . . . .  | . . . .  t . . . .  i . , ° , i . . . . .  
2 4 6 8 10 12 
Radiation Dose (C,v~ 
Fig. 4. The effects of radiation on the clonogenic survival of 
A431 cells. Cells were irradiated with increasing doses of radia- 
tion, in the presence or absence of 20 nM EGF or 100 nM TPA, 
replated, and clonogenic survival scored. 
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3.3. Resistance to radiation increases with elevated 
EGF but not with TPA 
To test whether modulation of PKC contributes to 
the sensitization of A431[ cells to radiation, we tested 
cell-sensitivity to radiation under conditions of ele- 
vated membranal PKC. Cells were treated with the 
tumor promoting agent, TPA, in doses which increase 
membranal PKC. The clonogenic survival of irradi- 
ated cells in the presence or absence of TPA was 
tested and compared to their survival in the presence 
or absence of EGF. As shown in Fig. 4, addition of 
EGF to the culture media during and after irradiation 
resulted in a significant increase in the clonogenic 
survival of the cells. This is evident from the minimal 
shoulder egion of Dq 5.6 Gy for cells irradiated in 
the presence of EGF, as compared to Dq of 0 Gy for 
cells exposed to radiation alone. However, as shown, 
treatment of cells with TPA had little effect on cell 
survival. 
3.4. Anti-EGFR monochmal ntibodies enhance radi- 
ation-induced apoptosis 
Since A431 cell resistance to radiation was in- 
creased by EGF-induced activation of EGFR but not 
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Fig. 5. The effect of anti-EGFR mAb (LA22) on apoptosis of 
irradiated A431 cells. Cells were incubated in the presence or 
absence of LA22 (20 nM) for 1 h at 37°C, and then were 
irradiated by 250 cGy in the presence or absence of EGF (20 
nM). Cells were allowed to recover for 15 min at 37°C, har- 
vested, and cell extract was analyzed for apoptosis. Results are 
compared to those of cells that were similarly treated but not 
irradiated (control), and are expressed as % of control. 
by TPA-induced activation of PKC, the effects of 
LA22 monoclonal antibodies (mAb), which inhibits 
activation of the EGFR [24], was tested on A431 
apoptosis. As shown in Fig. 5, low levels of apopto- 
sis were observed either in irradiated (with no EGF 
added) or in irradiated and EGF-treated cells. A 
pronounced increase in radiation-induced apoptosis 
was observed only when cells were pretreated with 
LA22, even when treated together with EGF. How- 
ever, as shown, EGF reduced the LA22 augmentation 
of radiation-induce apoptosis. At the same time, treat- 
ment with either EGF or LA22 (without radiation) 
produced almost no effects on the level of apoptosis 
(not shown). 
4. Discussion 
To investigate which second messenger system is 
affected by radiation in A431 cells, we studied the 
effect of radiation on DAG (the physiological activa- 
tor of PKC), as well as on cellular ceramide and 
sphingosine contents. We also analyzed the effect of 
radiation on PKC activity and its cellular localization. 
Our results indicate that while ceramide levels de- 
crease in irradiated A431 cells, sphingosine levels 
increase. Moreover, radiation reduces DAG contents 
and concomitantly PKC is translocated to the cyto- 
plasm. 
Recent articles [1,4,5] have reported that ceramide, 
the second messenger of the sphingomyelin pathway, 
triggers program cell death (apoptosis) in response to 
ionizing radiation or activation of Fas. In contrast, he 
role of the sphingomyelin pathway in CD28 signaling 
of NFkB activation and mitogenesis in Jurkat cells 
has been reported [25,26]. Ceramide thus emerges as 
a pleiotropic biologic activator capable of inducing 
two mutually exclusive cellular functions, such as 
cell proliferation and cell death [27]. 
Our results in A431 cells show that radiation does 
not increase ceramide levels, but rather reduces ce- 
ramide contents. At the same time, no DNA ladder, 
which is indicative of apoptosis, could be observed. 
Perhaps the decreased levels of ceramide in irradiated 
A431 cells protects cells from apoptosis. It is still 
unknown whether in A431 cells sphingomyelinase 
(SMase) or ceramide-synthase r down regulated by 
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radiation, and thus production of ceramide is reduced, 
or whether ceramide-deacylase i  activated, thus 
causing enhanced ceramide breakdown into sphingo- 
sine. 
Increasing doses of radiation ot only elevate sph- 
ingosine contents (which are potential inhibitors of 
PKC [28]) but also reduce DAG levels. Therefore 
PKC is translocated to the cytoplasm and its mem- 
brane activity is inhibited both by the reduction of 
DAG levels [23] and by the increased levels of 
sphingosine [28]. It has been postulated that PKC 
activation may inhibit apoptosis [29,30], and that 
inhibition of PKC should enhance sensitization to 
radiation [1]. However, this model may not be appli- 
cable in tumor epithelial cells. Artificial attempts to 
upregulate PKC by short-time treatment with TPA 
failed to affect A431 cell survival. This is substantiat- 
ing the notion that in a carcinoma cell line such as 
A43 l, PKC may not play the dominant role in radia- 
tion-induced resistance. On the other hand, when 
cells were exposed to radiation in the presence of 
EGF, cells became less radio-sensitive, asdetermined 
by clonogenic survival experiments. 
We have recently shown in A431 cells [18] that 
radiation mimics the effect of the natural ligand 
(EGF) on its receptor (EGFR) by inducing fast 
(s/min) receptor tyrosine (Tyr) phosphorylation a d 
increasing its Tyr kinase activity. However, the 
mechanism of which radiation induces modulation of 
EGFR and its precise role in the growth response 
remain unclear. Matsuo et al. [31] have shown that 
EGF binding was suppressed 3-5 h after 100 cGy via 
a PKC-dependent pathway, but the level of EGF 
dependent EGFR Tyr phosphorylation was not af- 
fected. Taken together, these findings may indicate 
that the cell responds to radiation by immediate 
(s/min) signals at the plasma membrane followed by 
slower responses (h). While the immediate response 
is a change in EGFR Tyr phosphorylation and PKC 
down modulation, later responses [31] may change 
EGF affinity to its receptor via PKC modulation. 
These studies do not rule out a role for radiation as 
biomodulator f other mechanisms involved in cellu- 
lar growth, but they suggest that the capacity of 
radiation to alter A431 cell proliferation may partially 
reside in its ability to act as a direct biomodulator f 
the phosphorylation a d function of the EGFR. In an 
epithelial tumor cell line with elevated EGFR, such 
as A431 cells, an optimal concentration of EGF is 
required to enhance proliferation [32]. Higher concen- 
trations of EGF can inhibit growth. There may be a 
quantitative r lationship between EGFR kinase activ- 
ity and growth response [33], and when an optimal 
amount of kinase activation is exceeded, growth inhi- 
bition may result. The identification of EGFR as a 
target of radiation and the distinction between the 
action of EGF and radiation on EGFR may supply 
important clues toward the understanding of the 
mechanisms through which radiation interacts with 
regulatory signal transduction pathways. 
Cell cycle analysis [34] suggested that both EGF 
and radiation caused G1 arrest in cycling A431 cells, 
providing further indication for the interaction of 
signaling pathways involved in cellular responses to 
EGF and radiation. Both radiation and nanomolar 
EGF treatment of A431 cells cause G1 arrest by 72 h 
post exposure [34]. The EGF effect is consistent with 
growth inhibitory effects of nanomolar EGF on A431 
cells [35], while the radiation effect is suggested to be 
additive with EGF-induced G1 arrest [34], consistent 
with the additive inhibitory effects of radiation and 
nmol EGF treatment. Therefore, it is possible that the 
EGF protection effect on A431 cells, demonstrated in 
our clonogenic experiments, is primarily a cell cycle 
arrest effect. These results pose an additional interest- 
ing question whether EGFR and its ligand could also 
contribute to programmed cell death. 
It has been shown recently in colorectal adeno- 
carcinoma Difi cells, which like A431 cells secrete 
TGFce and express high number of EGFR, that treat- 
ment with anti-EGFR mAb induced both cell cycle 
arrest in G1 phase and apoptosis [36]. It was hence 
suggested that blocking EGFR tyrosine kinase activ- 
ity with anti-EGFR mAb may lead to both cell cycle 
arrest and to apoptosis. Anti-EGFR mAb-induced 
apoptosis was delayed in Difi cells by the addition of 
the growth factor, while treatment with EGF alone, in 
the absence of the mAb, resulted in formation of a 
very faint DNA ladder. It was thus suggested that two 
events occur in the Difi cells deprived of the EGFR- 
mediated signal transduction pathway: First, cells 
accumulate in G1 phase, an event which is reversible, 
later, cells undergo apoptosis. It is possible that regu- 
lation of cell cycle traversal and regulation of apopto- 
sis are separable as suggested and shown in Difi cells 
[36]. 
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We measured the initial apoptotic response of 
A431 cells to EGF, to radiation and to mAb (LA22) 
to EGFR (which inhibits EGF and TGFa binding to 
the receptor and its Tyrs phosphorylation [24]). EGF 
alone slightly inhibited apoptosis, while LA22 slightly 
enhanced apoptosis in these cells. Moreover, radia- 
tion alone induced very low levels of apoptosis, but 
LA22 highly enhanced radiation-induced apoptosis 
by preventing the EGFR activation. We thus found 
that radiation-induced apoptosis could be enhanced 
by LA22, which blocks EGFR tyrosine kinase. EGF, 
which activates the tyrosine kinase activity of EGFR, 
could delay mAb LA22-induced apoptosis. In sum, 
only combined treatment of mAbs to EGFR (which 
inhibit EGFR activity) together with radiation en- 
hanced apoptosis. 
To conclude, our data suggest that in EGFR-over- 
expressing cancer cells, of the three checkpoints 
modulating cell sensitivity to radiation: Ceramide 
production, PKC and EGFR activation, EGFR activa- 
tion dominates the outcome of radiation. Up-modula- 
tion of PKC by TPA has no effect on A431 cell 
survival, but inhibition of EGFR by mAbs increases 
apoptosis of irradiated cells. In these carcinoma cells, 
PKC may have only a secondary and an indirect role 
in cell resistance to radiation. PKC down-modulates 
EGFR tyrosine kinase activity via EGFR Thr-664 
phosphorylation [37]. Thus radiation induced de- 
crease in membrane PKC may further augment EGFR 
tyrosine kinase activity, thereby increasing resistance 
to radiation. The same may apply to radiation-in- 
duced ceramide modulation in A431 cells. We have 
shown [6] that ceramide down-modulates EGFR tyro- 
sine kinase activity via ,Lhe EGFR Thr-669 phospho- 
rylation. Thus radiation-induced decrease in A431 
ceramide contents may further promote the EGFR 
tyrosine kinase activity and thus enhance resistance 
to radiation. In sum, the radiation-induced decrease in 
DAG cell contents followed by down-regulation of
membranal PKC and the parallel decrease in ce- 
ramide levels may jusl: amplify the net result of 
EGFR activation, which results in A431 cell resis- 
tance to radiation. 
Our results clearly suggest hat EGFR activation 
has a dominant role in protecting A431 cells from 
radiation damage at clinically-relevant radiation 
doses, while antibodies directed against he EGFR 
sensitize cells to radiation by inducing apoptosis. 
Thus, pretreatment with monoclonal ntibodies to the 
EGFR may be advantageous a a combined therapy 
with radiation in human epidermoid carcinoma. 
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